FGF10 and Human Lung Disease Across the Life Spectrum

Area of Science:

• Pulmonology and Developmental Biology
• Cellular and Molecular Medicine

Background:

• Lung diseases affect all age groups, from neonates to the elderly.
• Congenital lung structure abnormalities and environmental exposures contribute to lung disease.
• Fibroblast growth factor 10 (FGF10) plays a vital role in lung development and repair.

Purpose of the Study:

• To review the cellular and molecular mechanisms linking FGF10 to various lung diseases.
• To explore FGF10's role in lung morphogenesis, differentiation, and injury response.

Main Methods:

• Literature review of studies on FGF10 signaling in lung development and disease.
• Analysis of cellular and molecular pathways involving FGF10 in lung tissue.

Main Results:

• FGF10 signaling defects during development cause neonatal lung disease, such as bronchopulmonary dysplasia.
• FGF10 mutations are linked to congenital airway abnormalities and increased risk of adult chronic lung diseases, including cystic fibrosis.
• FGF10 is essential for maintaining airway progenitor cells and promoting alveolar regeneration after injury.

Conclusions:

• FGF10 is a key regulator in multiple lung diseases across the lifespan.
• Targeting FGF10 pathways may offer novel therapeutic strategies for diverse lung conditions.